Amsterdam Airport Schiphol has joined Pharma.Aero as a Strategic Member, reinforcing the organisation’s international network of stakeholders working to address the increasingly complex demands of healthcare and pharmaceutical supply chains.
The move brings one of Europe’s major aviation hubs into a global community dedicated to advancing pharmaceutical logistics through collaboration, innovation, resilience and sustainability.
With more than 300 direct destinations worldwide, Schiphol plays an important role in supporting international passenger and cargo flows. Its new role within Pharma.Aero will allow the airport to contribute its connectivity, operational expertise and industry knowledge to initiatives focused on the future of healthcare logistics.
Beyond its membership, Schiphol is expected to take an active part in Pharma.Aero’s strategic discussions and cross-industry projects. These initiatives bring together pharmaceutical manufacturers, logistics providers, airports, airlines, technology companies and academic institutions to develop solutions for the evolving needs of healthcare supply chains.
Amsterdam Airport Schiphol has joined Pharma.Aero as a Strategic Member.
The airport’s participation is intended to support collective efforts around innovation, resilience and sustainability, while also contributing to the development and sharing of best practices across the global pharmaceutical logistics ecosystem.
Frank Van Gelder, Secretary General of Pharma.Aero, welcomed Schiphol’s decision to become a Strategic Airport Member, highlighting the airport’s connectivity, international reach and experience.
“We are delighted to welcome Amsterdam Airport Schiphol to Pharma.Aero. As one of Europe’s leading connectivity hubs, Schiphol brings extensive expertise, global reach, and a strong ambition to further strengthen its pharmaceutical logistics capabilities.”
Van Gelder said Schiphol’s decision demonstrates both a commitment to the Pharma.Aero community and a willingness to engage, learn and collaborate with the diverse group of industry leaders represented within the organisation.
He added that Schiphol’s involvement in strategic discussions and industry initiatives would strengthen Pharma.Aero’s collective expertise while helping accelerate responses to the challenges facing healthcare supply chains.
“By taking an active role in our strategic discussions and industry initiatives, Schiphol will help strengthen the collective expertise of our organisation and accelerate efforts to address the evolving challenges facing healthcare supply chains. We look forward to working together to advance innovation, resilience, and best practices across the global healthcare logistics ecosystem”, added Van Gelder.
For Schiphol Cargo, the partnership reflects the airport’s broader ambition to work with supply chain partners on innovative and future-proof healthcare logistics solutions.
Eduard Molkenboer, Head of Schiphol Cargo, said global demand for dependable pharmaceutical logistics continues to increase, making cooperation across the entire supply chain increasingly important.
“Joining Pharma.Aero aligns perfectly with our ambition to work alongside partners in building innovative and future-proof healthcare supply chains. Global demand for reliable pharmaceutical logistics continues to grow, requiring strong collaboration across the entire supply chain.”
Molkenboer pointed to Schiphol’s network of more than 300 direct destinations, its extensive cargo community, strategic geographic position and close cooperation with Maastricht Aachen Airport as key strengths that can support this ambition.
Through these capabilities, Schiphol aims to contribute to greater reliability, predictability and quality across healthcare logistics worldwide.
“Together with Pharma.Aero, we look forward to contributing to the future of healthcare logistics,” Molkenboer concluded.
